Position in CERS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$456,219
-$70,203 QoQ
Shares Held
250,670
-1.9% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026RAYMOND JAMES FINANCIAL INC holds $2,778,023,742 across 53 Medical Devices names. CERS ranks #45 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
7,382,158 | $639,663,988 | |
| 2 | ABT |
Abbott Laboratories
|
5,264,261 | $540,481,675 | |
| 3 | SYK |
Stryker Corp
|
1,023,471 | $336,302,333 | |
| 4 | STE |
STERIS plc
|
1,029,808 | $227,721,440 | |
| 5 | BSX |
Boston Scientific Corp
|
3,029,097 | $190,075,835 | |
| 6 | EW |
Edwards Lifesciences Corp
|
2,224,213 | $178,114,975 | |
| 7 | DXCM |
Dexcom Inc
|
2,782,627 | $174,748,973 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
1,249,368 | $88,930,013 |
All Filings in CERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $456,219 | 250,670 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $526,422 | 255,545 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $397,770 | 250,170 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $328,769 | 233,170 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $330,407 | 237,703 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $375,871 | 244,073 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||